Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Cynapsus Therapeutics Inc

+ Add to Watchlist

CYNAF:US

1.0430 USD 0.0230 2.25%

As of 15:24:17 ET on 03/05/2015.

Company Profile for Cynapsus Therapeutics Inc (CYNAF)

Cynapsus Therapeutics, Inc. researches and develops pharmaceuticals. The Company researches treatments for Parkinson's disease, neuropathic pain associated with multiple sclerosis and cancer, and nausea and vomiting and appetite stimulation.

Contact Information

Cynapsus Therapeutics Inc

828 Richmond Street West
Toronto, ON M6J 1C9
Canada
Phone: 1-416-703-2449
Fax: 1-416-703-8752

Key Executives for Cynapsus Therapeutics Inc (CYNAF)

Anthony J GiovinazzoPresident/CEOAndrew Michael WilliamsCFO/COO
Thierry BilbaultExec VP:CMC/Chief Scientific Ofcr

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil